Definitive Healthcare
About: Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
Employees: 782
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
688% more call options, than puts
Call options by funds: $134K | Put options by funds: $17K
42% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 36
16% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 19
2% more funds holding
Funds holding: 125 [Q3] → 128 (+3) [Q4]
0.25% more ownership
Funds ownership: 90.65% [Q3] → 90.9% (+0.25%) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]
9% less capital invested
Capital invested by funds: $475M [Q3] → $432M (-$43M) [Q4]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$3
19%
upside
Avg. target
$3
19%
upside
High target
$3
19%
upside
2 analyst ratings
0 positive
0%
1 neutral
50%
1 negative
50%
Goldman Sachs Kash Rangan 39% 1-year accuracy 11 / 28 met price target | 19%upside $3 | Neutral Maintained | 4 Mar 2025 |
Barclays Saket Kalia 50% 1-year accuracy 28 / 56 met price target | 19%upside $3 | Underweight Maintained | 3 Mar 2025 |
Financial journalist opinion
Neutral
GlobeNewsWire
2 weeks ago
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare's new SVP of Growth and Sales Operations, an inducement award consisting of 364,432 time-based restricted stock units (“RSUs”), effective April 3, 2025. These awards were individually negotiated and granted as an inducement material to Mr. Moyer's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Neutral
GlobeNewsWire
1 month ago
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Kate Hastings, Definitive Healthcare's new Chief Customer Officer an inducement award consisting of 172,414 time-based restricted stock units (“RSUs”) effective March 3, 2025 and granted Benjamin Graboske, Definitive Healthcare's new EVP, Technology, Engineering and Chief Data Officer an inducement award consisting of 1,018,330 time-based RSUs, effective March 3, 2025. Each of these awards was individually negotiated and was granted as an inducement material to Ms. Hastings' and Mr. Graboske's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Negative
Zacks Investment Research
1 month ago
New Strong Sell Stocks for March 4th
Teaser: AMRC, DH and AAON have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2025.
Neutral
Seeking Alpha
1 month ago
Definitive Healthcare Corp. (DH) Q4 2024 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Jared Haase - William Blair Hanna Lee - Bank of America Jenny Shen - BTIG David Grossman - Stifel Maxi Ma - Deutsche Bank Johnathan McCary - Raymond James Craig Hettenbach - Morgan Stanley Jeff Garro - Stephens Operator Welcome to Definitive Healthcare's Q4 2024 Earnings Call. [Operator Instructions] I would like to now turn the call over to your host.
Positive
Zacks Investment Research
1 month ago
Definitive Healthcare Corp. (DH) Q4 Earnings and Revenues Surpass Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.
Neutral
GlobeNewsWire
1 month ago
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024
FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2024.
Neutral
GlobeNewsWire
1 month ago
Definitive Healthcare to Present at the Raymond James 2025 Institutional Investors Conference
FRAMINGHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and its Chief Financial Officer, Rick Booth, will present at the Raymond James 2025 Institutional Investors Conference.
Positive
Zacks Investment Research
1 month ago
DH or FFIV: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Internet - Software sector have probably already heard of Definitive Healthcare Corp. (DH) and F5 Networks (FFIV). But which of these two stocks presents investors with the better value opportunity right now?
Neutral
GlobeNewsWire
2 months ago
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its fourth quarter and full year ended December 31, 2024, on Thursday, February 27, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
Positive
Seeking Alpha
2 months ago
A Dive Into Definitive Healthcare
Definitive Healthcare trades at a discount to the overall market based on P/E, and a new CEO with a focus on simplifying operations but faces declining profits and revenues. The company also has recently announced a new $100 billion stock buyback authorization and is seeing significant unlevered free cash flow. A first look at Definitive Healthcare follows in the paragraphs below.
Charts implemented using Lightweight Charts™